Preview Newsletter

Cosmetic Talc Litigation Media Coverage November 03, 2016

    Client Attorney Privileged/Attorney Work Product/At Request of Counsel

    US Coverage

  1. Jury awards cancer sufferer $70m following Johnson & Johnson lawsuit

    Nov 3, 2016 | Cosumnes Connection

    By Joanne Flowers

    The juries found Johnson & Johnson failed to warn the public of studies linking its talc-containing products like Shower-to-Shower product and Johnson's Baby Powder to ovarian cancer and conspiring to hide the truth, said Jim Onder, one of the lead attorneys.
  2. J&J Still Says Talc Is Safe After $70 Million Verdict

    Nov 3, 2016 | Consumer Advocacy News

    By Andrew Steinberg

    Last week’s $70 Million Baby Powder Verdict confirmed what thousands of women already learned firsthand: baby powder can cause ovarian cancer.
  3. $70M JURY AWARD TO CALIFORNIA WOMAN IN BABY POWDER LAWSUIT

    Nov 2, 2016 | The Legal Examiner

    By Andrew D'Arcy

    Last Thursday, a St. Louis jury awarded a California woman more than $70 million in her lawsuit alleging that years of using Johnson & Johnson’s baby powder caused her cancer, the latest case raising concerns about the health ramifications of extended talcum powder use.
  4. America’s Lawyer Coming Soon To RT

    Nov 2, 2016 | The Ring of Fire Network

    ...When we talk about the talc case of Johnson & Johnson and how Johnson & Johnson knew about the dangers of their powder decades ago, and how they intentionally covered it up.
  5. APAC Coverage

  6. Most domestic talcum powder brands safe, certifies FDA

    Nov 3, 2016 | The Times of India

    ays after a US court granted a compensation of $70 million to a 62-year-old whose ovarian cancer was linked to the sustained use of Johnson and Johnson's powders, the state Food and Drug Administration (FDA) has certified most domestic talcum powder brands as asbestos-free and complaint with safety norms.

    Client Attorney Privileged/Attorney Work Product/At Request of Counsel

    US Coverage

  1. Jury awards cancer sufferer $70m following Johnson & Johnson lawsuit

    Nov 3, 2016 | Cosumnes Connection

    By Joanne Flowers

    The juries found Johnson & Johnson failed to warn the public of studies linking its talc-containing products like Shower-to-Shower product and Johnson's Baby Powder to ovarian cancer and conspiring to hide the truth, said Jim Onder, one of the lead attorneys.

    Deborah Giannecchini, 62, was diagnosed with cancer three years ago and, according to her lawyers who have consulted medical professionals, despite her having undergone surgery, radiation and chemotherapy, she has an 80 percent chance of dying in the next two years.

    Johnson & Johnson will appeal the verdict, its spokeswoman Carol Goodrich said.

    While Beasley Allen has had success in Missouri, they have not had success with talcum powder lawsuits against Johnson & Johnson in the company's home state of New Jersey.

    The jury awarded Giannecchini $70 million after she was diagnosed with ovarian cancer. Although some organizations such as the International Agency for Research on Cancer label talc as "possibly carcinogenic", government institutions have not evaluated the incidence of baby powder in the development of ovarian cancer.

    But Onder of the Onder Law Firm in suburban St Louis, which represented plaintiffs in all three St. Louis cases, cited other research that began connecting talcum powder to ovarian cancer in the 1970s.

    Two other jury trials in St. Louis reached similar outcomes earlier this year, awarding the plaintiffs $72 million and $55 million. Jerry Beasley says, "Johnson and Johnson knew of the association with ovarian cancer starting back in 1979". The October 27 verdict marks the third consecutive time this year that a jury has awarded substantial damages in a case involving Johnson & Johnson's talc-based powders and the potentially deadly disease.

    A Johnson & Johnson spokesperson said it will appeal the verdict, but there are still hundreds of pending cases. "I don't want anyone else to battle this terrible disease", said Giannecchini". Co-defendant Imerys Talc America, the supplier of the talc, was hit with $2.5 million in??punitive damages.

    Johnson & Johnson said in a statement that it sympathizes with women and their families impacted by ovarian cancer, but science has shown no link with talcum powder. While several studies have found no link between perineal talc use and ovarian cancer, several others have found a risk associated between the two.

    Talc is the softest of minerals that is crushed into a white powder and widely used in cosmetics and personal hygiene products to absorb moisture.

    Onder said he expects J&J won't put a warning on its products and will continue a "scorched-earth legal policy" despite the recent verdicts.

    http://crcconnection.com/2016/11/02/jury-awards-cancer-sufferer-70m-following-johnson-johnson.html

    Return to headline | Return to top

  2. J&J Still Says Talc Is Safe After $70 Million Verdict

    Nov 3, 2016 | Consumer Advocacy News

    By Andrew Steinberg

    Last week’s $70 Million Baby Powder Verdict confirmed what thousands of women already learned firsthand: baby powder can cause ovarian cancer. A St. Louis jury listened to testimony explaining more than 20 epidemiological studies confirming the link between the talc in baby powder and ovarian cancer and concluded the plaintiff’s long-term baby powder use was the cause of her cancer. Despite mounting evidence of the dangers of talc, Johnson & Johnson (J&J) still defends the safety of its products.

    Carol Goodrich, a spokeswoman for J&J, stated the company sympathizes with the families of women impacted by ovarian cancer, but the company “will appeal [the] verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder.”

    Despite the company’s beliefs, the science supporting the safety of baby powder hasn’t been convincing enough for juries. J&J’s stubbornness could end up being very costly. The next baby powder cancer trial is scheduled for January 2017, but the company faces thousands of additional lawsuits, and it is likely many more will be filed.

    But the heartache is likely not over for J&J. The company also faces an ongoing trial regarding its defective Pinnacle hip implant in a Texas courtroom. The previous Pinnacle hip implant trial yielded a $502 million verdict for the plaintiff, and the ongoing trial could see another huge win for plaintiffs. The trial is anticipated to take another one to two weeks.

    Once the hip implant trial concludes, J&J will still have to face thousands of lawsuits over its blood thinner Xarelto and its antipsychotic Risperdal. In the Xarelto litigation, which includes more than 9,000 lawsuits, and in the Risperdal litigation, which includes more than 13,000 Lawsuits, plaintiffs allege J&J failed to warn them of the risks associated with the drugs.

    In total, the company faces more than 75,000 lawsuits. The mounting number of lawsuits might convince J&J to cut its losses and settle some of these litigations.

    http://baddrug.news/news/jj-still-says-talc-safe-70-million-verdict/

    Return to headline | Return to top

  3. $70M JURY AWARD TO CALIFORNIA WOMAN IN BABY POWDER LAWSUIT

    Nov 2, 2016 | The Legal Examiner

    By Andrew D'Arcy

    Last Thursday, a St. Louis jury  awarded a California woman  more than $70  million in her  lawsuit alleging that years  of  using Johnson  & Johnson’s baby powder caused her cancer, the latest case raising concerns about  the  health  ramifications of  extended  talcum powder use.  Johnson & Johnson lost a third straight trial after three hours of deliberations.

    According  to  the  Los Angeles Times, Deborah  Giannecchini, 63, said  she had used Johnson  & Johnson for  feminine  hygiene for 45  years  before she was diagnosed with ovarian cancer in  2012.  The lawsuit accused Johnson & Johnson  of “negligent conduct” in  making and marketing  its  baby powder.

    In addition to the monetary compensation she received, Giannecchini said she hoped  Johnson  & Johnson  would  more clearly present the risks  associated  with using  talcum  powder.  “I hope  that Johnson  & Johnson will step up and  take responsibility and post a warning on their product that  says  this is not as  safe as you may  think it  is and  think about it  before you decide  to use this  product,” she said.

    About 1,700 lawsuits in state  and federal courts  have  been  filed  against  Johnson & Johnson  for  failing to  warn  consumers  that its baby powder  and Shower-to-Shower talc products may  cause  ovarian cancer.  Earlier this year, the  company lost $72 million  and $55 million  in the first two talc claims  in  St.  Louis.

    http://atlanticcity.legalexaminer.com/defective-dangerous-products/70m-jury-award-to-california-woman-in-baby-powder-lawsuit/


    Return to headline | Return to top

  4. America’s Lawyer Coming Soon To RT

    Nov 2, 2016 | The Ring of Fire Network

    Mike Papantonio & Sam Seder talk about how mainstream media has become corporate media, and the importance a new TV show like “America’s Lawyer” will have.

    https://youtu.be/S3l-ZiWQAyE

    Transcription of the above video:

    Seder:
    Pap, one of the things I’ve been wanting to talk to you about and it is obviously not just peripheral but it’s right on point with a lot of the things that we talk about on this program. Obviously, a lot of the things that you do on a day-to-day basis, whether it’s holding chemical companies accountable for their dumping their chemicals in our water, or medical makers responsible for putting out products that they haven’t tested well enough for safety, is the launch of your new TV show.

    Papantonio:
    Yes. America’s Lawyer, it is going to be launching just a couple of weeks with RT America and it’ll show also with RT International. I think it’s going to show in every english-speaking country in the world, 70 million people. The reason that it’s so important, Sam, is because as we’ve said … You and I have talked about so many times, corporate media in the US is virtually dead. The chances of corporate media of telling these stories are not just existent.

    If you turn on the television tonight and you watch the nightly news, in that hour of nightly news you’re going to see an average of seven pharmaceutical advertisements. The problem with that is when you’ve got advertisers like Pfizer, and Merck, and Bayer, and Johnson & Johnson. When you have all these advertisers that you’re counting on for all of your money just so the CEO can make big bonuses, you’re not going to run stories that talk about a pharmaceutical that might be killing people by the thousands all over the country, and in fact, all over the world, so the stories don’t get told.

    With RT America, part of the agreement for me to do the story is that I got to be able to tell the stories. If it’s oil and gas company that’s polluting a river, I got to tell stories like DuPont basically just thrashing the Ohio river. With RT America I’m able to do that. It’s a very different program. I got to tell you, there’s not another duplicate of it anywhere.

    You can’t watch CNN and listen to that character, whatever his name is, the CNN … I can’t [remember 00:02:27] his name right now but is their in-house lawyer. He doesn’t have the ability to tell stories like this, he’s not even a trial lawyer so he doesn’t have stories like this. Certainly, his network would not even allow him to tell those stories. It’s a very different product, there won’t be another one like it.

    Seder:
    It’s impossible to imagine it. I mean for a couple of reasons. One as you say … If there’s any doubt, and I don’t know why people would necessarily have any doubt about it, but if there was any doubt that these advertisers, I mean you can just look to something even like a small … There was a big scandal about VICE maybe about a year, year and a half ago, that VICE was actually changing their coverage of the NFL because they were hoping to do some type of program with the NFL in the future. This is the way these news outfits are just part of a larger entertainment package. They exist to make money, and they don’t want to offend their primary customer which is this big corporate, many times, [manufacturing 00:03:46].

    Papantonio:
    Sam, it’s amazing. Here, again, this is a program that will show to 70 million people, every english-speaking country in the world will hear America’s Lawyer, and they’re going to be hearing form the lawyers that actually have the big pharmaceutical cases. We’ll be hearing from the clients that have suffered because of whatever that pharmaceutical company did. We’re going to hear from the best environmental lawyers in the world talking about a company thrashing a major waterway.

    Those are not stories that you will ever hear from corporate media. The advantage I have is, A, we’ve reached out to lawyers all over the country and said, “Look, if you have filed a case, the only stipulation is the case has got to be filed, and we have to be supplied documents, and we have to be able to talk to a clients.” The show will focus on that case for about the first half of the show, and then we’ll be talking about kind of a diverse bunch of issues dealing with the law.

    I think the importance of America’s Lawyer is, when I tell you there will not be another show like it, I promise you that will be the case. When we talk about the talc case of Johnson & Johnson and how Johnson & Johnson knew about the dangers of their powder decades ago, and how they intentionally covered it up. We’re not just going to say it, we’ll actually have the documents up on the screen where we show you that, and we’ll have the lawyer who actually tried the cases against Johnson & Johnson on the show. It’s a very different product.

    Seder:
    I got to say, one of my special request too is that I think so little attention, particularly on the left is paid to the supreme court, but also particularly even beyond that, as a subset of things that are ignored in terms of the court is the question of how the court … Even in this instance, the four five split that we’ve seen for years is often far greater when it comes to barring access to the courtroom. Is this a topic that you guys will be talking about?

    Papantonio:
    Yes.

    Seder:
    Because again, these are topics that we hear nowhere else.

    Papantonio:
    It’s impossible to talk about a legal story now without involving the back story, dealing with the Chamber of Commerce, or associated industries, or ALEC. It’s impossible to tell these stories without showing what lengths these organizations are going to so these stories are never told. As a matter of fact, RT America, as soon as we start doing theses stories is just going to be covered up with lobbyist calling about how dare you.

    The difficulty is RT has the guts to say, “You know what, this is what we’re gonna do. We don’t get money from your advertising, we think the story is important and we’re gonna run it anyway.” That’s the commitment I got from RT America and RT International to do the show. When they show it in every english-speaking country in the world, sometimes it’s going to be showing right in the back yard of a company that might be manufacturing the product. The politics really come home to roost right there in their back yard.

    I’m a trial lawyer, I’ve spent countless hours pouring through documents to tell the story about the ugly side of corporate America. Corporate media refuses to talk about these issues. I’m going to paint a clear picture about how disturbing, how corrupt corporate conduct has become in modern America. These are stories that no one else can tell. I’m Mike Papantonio, host of America’s Lawyer. Question more.

    We’re uncovering stories everyday on America’s Lawyer that nobody is talking about. If you have a case that you want us to talk about, get in touch.

    https://trofire.com/2016/11/02/americas-lawyer-coming-soon-to-rt/

    Return to headline | Return to top

  5. APAC Coverage

  6. Most domestic talcum powder brands safe, certifies FDA

    Nov 3, 2016 | The Times of India

    MUMBAI: Days after a US court granted a compensation of $70 million to a 62-year-old whose ovarian cancer was linked to the sustained use of Johnson and Johnson's powders, the state Food and Drug Administration (FDA) has certified most domestic talcum powder brands as asbestos-free and complaint with safety norms.



    The ten-odd brands that were collected from the market and tested in an FDA lab as well as an independent one also includes the Johnson and Johnson powders. The samples of DermiCool, Nycil, Ponds, J&J's Shower-to-Shower and Baby powder were collected in March after a US court's had granted damages to a 62-year old woman, who died due to ovarian cancer.



    "The talcum powder that is manufactured here is asbestos-free. Most brands have complied with the safety norms," said FDA commissioner Harshadeep Kamble. A senior FDA official added that the tests were carried out in independent private laboratories to check for the presence of asbestos in talc. Talcum, a powdered mineral commonly found in feminine hygiene products, powders, cosmetics, etc, in its natural form contains asbestos which is a known carcinogen.



    FDA's joint commissioner OP Sadhwani however said, "We cannot comment on whether or not there is a cancer risk. That is a subject of independent research. We have only found out that the products don't contain asbestos," he said. A J&J India spokesperson, in a previous communication had told TOI, "Any amount of talc used in a consumer product is required to be asbestos-free and has been since the 1970s - though misperceptions still exist that talc products contain asbestos, a substance with links to cancer."

    http://timesofindia.indiatimes.com/city/mumbai/Most-domestic-talcum-powder-brands-safe-certifies-FDA/articleshow/55213510.cms

    Return to headline | Return to top

Add recipients

Suggested